Keywords: لنفوم غیر هوچکین; non-Hodgkin lymphoma; total knee arthroplasty;
مقالات ISI لنفوم غیر هوچکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لنفوم غیر هوچکین; HL; Hodgkin lymphoma; NHL; Non-Hodgkin lymphoma; PEDS; Patient Epidemiology Data System; OR; odds ratio; CI; confidence interval; Hodgkin lymphoma risk; Non-Hodgkin lymphoma risk; Physical inactivity;
Keywords: لنفوم غیر هوچکین; ADC; apparent diffusion coefficient; CL; composite lymphoma; CHL; classical Hodgkin lymphoma; CT; computed tomography; DWI; diffusion weighted imaging; FL; follicularlymphoma; FSE; fast spin eco; GI; gastrointestinal; HB; haemoglobin; MALT; mucosa-associa
Keywords: لنفوم غیر هوچکین; Cancer survivor; Complementary alternative medicine; Hodgkin disease; Non-Hodgkin lymphoma; Quality of life;
Keywords: لنفوم غیر هوچکین; ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; APL; acute promyelocytic leukaemia; ASR; age standardised incidence rates; CI; confidence interval; CML; chronic myeloid leukaemia; ECP; Eastern Cape Province; HMs; haematological malignanc
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Older patients; Population-based study;
Keywords: لنفوم غیر هوچکین; Superior vena cava syndrome (SVCS); Thrombosis; CT scan; Radiotherapy; Chemotherapy; Stenting; Carcinoma; Non-Hodgkin lymphoma;
Keywords: لنفوم غیر هوچکین; ABC; activated-B Cell; BTK; Bruton's tyrosine kinase; CNS; Central nervous system; CLL; chronic lymphocytic leukemia; DLBCL; Diffuse Large B-cell lymphoma; DAB; diaminobenzidin; DNMT; DNA methyltransferase; GO; gene ontology; GCB; germinal center cell lik
Keywords: لنفوم غیر هوچکین; Primary immunodeficiency; Hematologic malignancy; Lymphoma; Leukemia; Hodgkin; AD; Autosomal dominant; ADA; Adenosine deaminase; AML; Acute myeloid leukemia; AR; Autosomal recessive; CID; combined immunodeficiency; HL; Hodgkin lymphoma; HLH; Hemophagocyti
Keywords: لنفوم غیر هوچکین; comorbidities; hematologic malignancies; leukemia; multiple myeloma; non-Hodgkin lymphoma; pemphigus; CI; confidence interval; OR; odds ratio;
Keywords: لنفوم غیر هوچکین; IL; interleukin; SLE; systemic lupus erythematosus; SNPs; single nucleotide polymorphisms; IFN; Interferon; TGF; transforming growth factor; BAFF; B cells-activating factor; GWAS; genome-wide association studies; ACR; American College of Rheumatology; HWE
Keywords: لنفوم غیر هوچکین; HIV; Autologous transplantation; Non-Hodgkin lymphoma; Multiple myeloma;
Keywords: لنفوم غیر هوچکین; Primary immunodeficiency; malignancy; tumor predisposition; immune surveillance; pre-existing condition; ALL; Acute lymphoblastic leukemia; ALPS; Autoimmune lymphoproliferative syndrome; AT; Ataxia teleangiectasia; CHH; Cartilage-hair hypoplasia; CID; Com
Keywords: لنفوم غیر هوچکین; DLBCL; diffuse large B-cell lymphoma; R-CHOP; rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; NHL; non-Hodgkin lymphoma; GEP; gene expression profiling; COO; cell-of-origin; GCB; germinal center B-cell; ABC; activated B-cell; PMBL;
Keywords: لنفوم غیر هوچکین; B-cell lymphoma; MCL; Non-Hodgkin lymphoma; Randomized controlled trials; Systematic published data review;
Keywords: لنفوم غیر هوچکین; RDD; random digit dialing; NHL; non-Hodgkin lymphoma; Case-control studies; Epidemiologic methods; Non-Hodgkin lymphoma;
Keywords: لنفوم غیر هوچکین; Veterans; Military; Leukaemia; Hodgkin lymphoma; Non-Hodgkin lymphoma; Retrospective cohort study;
Keywords: لنفوم غیر هوچکین; Hodgkin lymphoma; lymphoma; lymphoma frequency; non-Hodgkin lymphoma; Taiwan;
Keywords: لنفوم غیر هوچکین; Aggressive; Classification; immuno-chemotherapy; indolent; non-Hodgkin lymphoma; novel agents; prognosis;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Emergency presentation; Survival; Diffuse-large b-cell lymphoma;
Keywords: لنفوم غیر هوچکین; Plasma phospholipid profile; Chemotherapy; Non-Hodgkin lymphoma;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Renal cancer; Second cancer; Second malignant neoplasm; Thyroid cancer;
Keywords: لنفوم غیر هوچکین; Lymphoma; Non-Hodgkin lymphoma; Drug resistance; Vincristine; Quercetin;
Keywords: لنفوم غیر هوچکین; PCR; polymerase chain reaction; DLBCL; diffuse large B-cell lymphoma; SMZL; splenic marginal zone lymphoma; WHO; World Health Organization; NHL; non-Hodgkin lymphoma; RLH; reactive lymphoid hyperplasia; CT; computed tomography; Cytogenetics; Lymph node; L
Keywords: لنفوم غیر هوچکین; HR; hazard ratio; CI; confidence interval; PM2.5; particulate matter with a mean aerodynamic diameter < 2.5 μm; NO2; nitrogen dioxide; ALL; acute lymphoid leukemia; AML; acute myeloid leukemia; NHL; non-Hodgkin lymphoma; Prenatal; Air pollution; Childh
Keywords: لنفوم غیر هوچکین; ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: لنفوم غیر هوچکین; Polychlorinated biphenyls; PCB; Cancer; Melanoma; Non-Hodgkin lymphoma; Review; Meta-analysis;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Organophosphate pesticides; Meta-analysis;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Ovary; Lymphoblastic lymphoma;
Keywords: لنفوم غیر هوچکین; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; KIs; Non-Hodgkin lymphoma; RT;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Marginal zone lymphoma; Transformation; Aggressive lymphoma;
Keywords: لنفوم غیر هوچکین; Double expressing lymphoma; High-grade lymphoma; MYC-driven lymphomas; Non-Hodgkin lymphoma; Therapeutic options;
Keywords: لنفوم غیر هوچکین; Methotrexate; Genetic polymorphisms; Pharmacogenetics; Acute lymphoblastic leukemia; Non-Hodgkin lymphoma;
Keywords: لنفوم غیر هوچکین; Anthracycline; Follicular lymphoma; Grade 3; Non-Hodgkin lymphoma; Rituximab;
Keywords: لنفوم غیر هوچکین; Hodgkin lymphoma; Non-Hodgkin lymphoma; Radiotherapy; Breast dose reduction; Heart dose reduction; Inclined board;
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Venous thromboembolism; Risk; Cancer; Thrombosis;
Keywords: لنفوم غیر هوچکین; Brain and spinal cord; CNS relapse; Cox proportional hazards; Non-Hodgkin lymphoma; SCNSL;
Keywords: لنفوم غیر هوچکین; Hodgkin's disease; Non-Hodgkin lymphoma; Haploidentical stem cell transplantation; Post-transplantation cyclophosphamide; Melphalan conditioning
Keywords: لنفوم غیر هوچکین; Burkitt; diffuse large B-cell; lymphoblastic; non-Hodgkin lymphoma; tumour biology; tumour lysis
Keywords: لنفوم غیر هوچکین; Combined modality therapy; Early stage; Non-Hodgkin lymphoma; Radiotherapy; Survival;
Keywords: لنفوم غیر هوچکین; Autograft absolute lymphocyte count; Apheresis machine; Non-Hodgkin lymphoma; Autologous peripheral hematopoietic blood stem cell transplantation;
Keywords: لنفوم غیر هوچکین; Chemotherapy; hepatoblastoma; neuroblastoma; non-Hodgkin lymphoma; radiotherapy; rhabdomyosarcoma; sacrococcygeal teratoma; Wilms tumour
Keywords: لنفوم غیر هوچکین; Hematopoietic progenitor cell mobilization; Autologous transplant; Plerixafor; Multiple myeloma; Non-Hodgkin lymphoma
Keywords: لنفوم غیر هوچکین; Lymphoma; Non-Hodgkin lymphoma; MALToma; Ocular diseases
Keywords: لنفوم غیر هوچکین; RR; relative risk; CI; confidence intervals; SRR; summary relative risk; Non-Hodgkin lymphoma; Myeloma; Foods of animal origin; Meta-analysis;
Keywords: لنفوم غیر هوچکین; Allogeneic hematopoietic cell transplantation; Non-Hodgkin lymphoma; Elderly; Reduced-intensity conditioning
Keywords: لنفوم غیر هوچکین; Non-Hodgkin lymphoma; Lymphomas; Latin America;
Keywords: لنفوم غیر هوچکین; Follicular lymphoma; Non-Hodgkin lymphoma; Hematopathology
Keywords: لنفوم غیر هوچکین; Chronic lymphocytic leukemia; Non-Hodgkin lymphoma; Elderly;
Keywords: لنفوم غیر هوچکین; Lymphoma; Children; Non-Hodgkin lymphoma; Burkitt lymphoma; Lymphoblastic lymphoma; Diffuse large B-cell lymphoma; Anaplastic large cell lymphoma;